BIOMAT Database Logo BIOMAT Database Logo

Factor XII promotes blood coagulation independent of factor XI in the presence of long-chain polyphosphates. 2013

C Puy, and E I Tucker, and Z C Wong, and D Gailani, and S A Smith, and S H Choi, and J H Morrissey, and A Gruber, and O J T McCarty
Department of Biomedical Engineering, Oregon Health & Science University, Portland, OR, USA. puygarci@ohsu.edu

BACKGROUND Inorganic polyphosphates (polyP), which are secreted by activated platelets (short-chain polyP) and accumulate in some bacteria (long-chain polyP), support the contact activation of factor XII (FXII) and accelerate the activation of FXI. OBJECTIVE The aim of the present study was to evaluate the role of FXI in polyP-mediated coagulation activation and experimental thrombus formation. RESULTS Pretreatment of plasma with antibodies that selectively inhibit FXI activation by activated FXII (FXIIa) or FIX) activation by activated FXI (FXIa) were not able to inhibit the procoagulant effect of long or short-chain polyP in plasma. In contrast, the FXIIa inhibitor, corn trypsin inhibitor, blocked the procoagulant effect of long and short polyP in plasma. In a purified system, long polyP significantly enhanced the rate of FXII and prekallikrein activation and the activation of FXI by thrombin but not by FXIIa. In FXI-deficient plasma, long polyP promoted clotting of plasma in an FIX-dependent manner. In a purified system, the activation of FXII and prekallikrein by long polyP promoted FIX activation and prothombin activation. In an ex vivo model of occlusive thrombus formation, inhibition of FXIIa with corn trypsin inhibitor but not of FXI with a neutralizing antibodies abolished the prothrombotic effect of long polyP. CONCLUSIONS We propose that long polyP promotes FXII-mediated blood coagulation bypassing FXI. Accordingly, some polyp-containing pathogens may have evolved strategies to exploit polyP-initiated FXII activation for virulence, and selective inhibition of FXII may improve the host response to pathogens.

UI MeSH Term Description Entries
D010940 Plant Proteins Proteins found in plants (flowers, herbs, shrubs, trees, etc.). The concept does not include proteins found in vegetables for which PLANT PROTEINS, DIETARY is available. Plant Protein,Protein, Plant,Proteins, Plant
D011122 Polyphosphates Linear polymers in which orthophosphate residues are linked with energy-rich phosphoanhydride bonds. They are found in plants, animals, and microorganisms. Polyphosphate
D011516 Prothrombin A plasma protein that is the inactive precursor of thrombin. It is converted to thrombin by a prothrombin activator complex consisting of factor Xa, factor V, phospholipid, and calcium ions. Deficiency of prothrombin leads to hypoprothrombinemia. Coagulation Factor II,Factor II,Blood Coagulation Factor II,Differentiation Reversal Factor,Factor II, Coagulation,Factor, Differentiation Reversal,II, Coagulation Factor
D001777 Blood Coagulation The process of the interaction of BLOOD COAGULATION FACTORS that results in an insoluble FIBRIN clot. Blood Clotting,Coagulation, Blood,Blood Clottings,Clotting, Blood
D005172 Factor XI Stable blood coagulation factor involved in the intrinsic pathway. The activated form XIa activates factor IX to IXa. Deficiency of factor XI is often called hemophilia C. Coagulation Factor XI,Plasma Thromboplastin Antecedent,Blood Coagulation Factor XI,Factor 11,Factor Eleven,Antecedent, Plasma Thromboplastin,Factor XI, Coagulation,Thromboplastin Antecedent, Plasma
D005173 Factor XI Deficiency A hereditary deficiency of blood coagulation factor XI (also known as plasma thromboplastin antecedent or PTA or antihemophilic factor C) resulting in a systemic blood-clotting defect called hemophilia C or Rosenthal's syndrome, that may resemble classical hemophilia. Hemophilia C,Rosenthal Syndrome,Deficiency, Factor 11,Deficiency, Factor Eleven,Deficiency, Factor XI,Factor 11 Deficiency,Factor Eleven Deficiency,Plasma Thromboplastin Antecedent Deficiency,Rosenthal's Syndrome,Deficiencies, Factor 11,Deficiencies, Factor Eleven,Deficiencies, Factor XI,Factor 11 Deficiencies,Factor Eleven Deficiencies,Factor XI Deficiencies,Rosenthal Syndromes,Rosenthal's Syndromes,Rosenthals Syndrome,Syndrome, Rosenthal,Syndrome, Rosenthal's
D005174 Factor XII Stable blood coagulation factor activated by contact with the subendothelial surface of an injured vessel. Along with prekallikrein, it serves as the contact factor that initiates the intrinsic pathway of blood coagulation. Kallikrein activates factor XII to XIIa. Deficiency of factor XII, also called the Hageman trait, leads to increased incidence of thromboembolic disease. Mutations in the gene for factor XII that appear to increase factor XII amidolytic activity are associated with HEREDITARY ANGIOEDEMA TYPE III. Coagulation Factor XII,Hageman Factor,Factor 12,Factor Twelve
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013917 Thrombin An enzyme formed from PROTHROMBIN that converts FIBRINOGEN to FIBRIN. Thrombase,Thrombin JMI,Thrombin-JMI,Thrombinar,Thrombostat,alpha-Thrombin,beta,gamma-Thrombin,beta-Thrombin,gamma-Thrombin,JMI, Thrombin

Related Publications

C Puy, and E I Tucker, and Z C Wong, and D Gailani, and S A Smith, and S H Choi, and J H Morrissey, and A Gruber, and O J T McCarty
Activation of human blood coagulation factor XI independent of factor XII. Factor XI is activated by thrombin and factor XIa in the presence of negatively charged surfaces.
April 1991, The Journal of biological chemistry,
C Puy, and E I Tucker, and Z C Wong, and D Gailani, and S A Smith, and S H Choi, and J H Morrissey, and A Gruber, and O J T McCarty
Proceedings: Inhibition of blood coagulation factor XI-XII by monoclonal IgM.
December 1975, Israel journal of medical sciences,
C Puy, and E I Tucker, and Z C Wong, and D Gailani, and S A Smith, and S H Choi, and J H Morrissey, and A Gruber, and O J T McCarty
Rabbit blood coagulation factor XI. Mechanism of activation of rabbit Hageman factor (factor XII).
January 1979, Thrombosis research,
C Puy, and E I Tucker, and Z C Wong, and D Gailani, and S A Smith, and S H Choi, and J H Morrissey, and A Gruber, and O J T McCarty
Factor XII-independent activation of factor XI in plasma: effects of sulfatides on tissue factor-induced coagulation.
August 1993, Blood,
C Puy, and E I Tucker, and Z C Wong, and D Gailani, and S A Smith, and S H Choi, and J H Morrissey, and A Gruber, and O J T McCarty
Coagulation factor XI improves host defence during murine pneumonia-derived sepsis independent of factor XII activation.
July 2017, Thrombosis and haemostasis,
C Puy, and E I Tucker, and Z C Wong, and D Gailani, and S A Smith, and S H Choi, and J H Morrissey, and A Gruber, and O J T McCarty
Human blood coagulation factor XI. Purification, properties, and mechanism of activation by activated factor XII.
September 1977, The Journal of biological chemistry,
C Puy, and E I Tucker, and Z C Wong, and D Gailani, and S A Smith, and S H Choi, and J H Morrissey, and A Gruber, and O J T McCarty
[BLOOD COAGULATION IN FACTOR XI DEFICIENCY].
January 1963, Polskie Archiwum Medycyny Wewnetrznej,
C Puy, and E I Tucker, and Z C Wong, and D Gailani, and S A Smith, and S H Choi, and J H Morrissey, and A Gruber, and O J T McCarty
Hepatocytes express blood coagulation factor XII (Hageman factor).
April 1990, The Journal of laboratory and clinical medicine,
C Puy, and E I Tucker, and Z C Wong, and D Gailani, and S A Smith, and S H Choi, and J H Morrissey, and A Gruber, and O J T McCarty
Characterisation of blood coagulation factor XI T475I.
June 2005, Thrombosis and haemostasis,
C Puy, and E I Tucker, and Z C Wong, and D Gailani, and S A Smith, and S H Choi, and J H Morrissey, and A Gruber, and O J T McCarty
Associations between coagulation factor XII, coagulation factor XI, and stability of venous thromboembolism: A case-control study.
March 2022, World journal of clinical cases,
Copied contents to your clipboard!